Evolving Medical Practices Web-based Subscription Service_Special_Notice_RFI.pdf

The Government is performing market research by way of this Special Notice. IAW FAR 15.201, this is a Request for

Information only. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract.

Evolving Medical Practices Web-based Subscription Service Special Notice

1. TITLE: Defense Health Agency Enterprise – Evolving Medical Practices Web-based Subscription Service Request for Information (RFI)

2. INTRODUCTION: The mission of the Defense Health Agency (DHA) is to support our Nation by improving health and building readiness – making extraordinary experiences ordinary and exceptional outcomes routine. Accordingly, it is the vision of the DHA to embrace an unrelenting pursuit of excellence as we care for our joint force and those we are privileged to serve. Anytime, Anywhere – Always.

The DHA Medical Benefit and Reimbursement Branch (MB&R) is responsible for ensuring TRICARE policy is based on current evidence, is responsive to changes in the standard of care in the United

States and complies with the laws and regulations governing TRICARE. The MB&R develops program policy that allows beneficiaries to access new and emerging treatment but does not expose them to untested, unsafe, or ineffective (unproven) treatment which is specifically excluded from coverage by TRICARE regulation. Evolving Medical Practices Web-based Subscription Service is necessary to assess the safety and efficacy of new, emerging, and controversial health technologies. This requirement is established by law, that care must be medically necessary and appropriate, and proven safe and effective; this requirement is meant to assist the Government in meeting this statutory obligation. Moreover, the Evolving Medical Practices Web-based Subscription Service in question must include a proprietary rating process which is essential for DHA medical benefit determinations recommending whether a treatment is proven or unproven. Such a well-defined rating conclusion on whether the treatment is the standard of care or experimental closely aligns with TRICARE regulation.

3. AUTHORITY: The DHA Component Acquisition Executive is issuing this notice for the purpose of Market Research as required by the Federal Acquisition Regulation (FAR) 15.201 and FAR 10.002.

4. GOVERNMENT HEALTH TECHNOLOGY ASSESSMENT AND GEBETIC TESTING EVALUATION

REQUIREMENTS:

4.1 The contractor has the capability to provide a comprehensive web-based library consisting of evidence-based health technology assessment (HTA) and genetic test evaluation (GTE) reports on a wide range of healthcare technologies including: medical and surgical procedures; drugs and pharmaceuticals; diagnostic and screening tests including evaluations of genetic tests (e.g., lab developed tests); alternative therapies; and medical devices/equipment across a range of conditions and applications.

4.2 The contractor has the capability to provide a clear, objective view of the science behind the health technology, clinical evidence supporting the use of the technology, the manufacturer or laboratory involved in the development of the technology, an explanation of how the technology is used in clinical practice, whether professional guidelines support use of the technology, and whether representative public and private payers reimburse for the technology.

The Government is performing market research by way of this Special Notice. IAW FAR 15.201, this is a Request for

Information only. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract.

5.3 The contractor has the capability to provide a proprietary rating process which assigns a score reflecting the strength and direction of the evidence for a medical technology (procedure, test, device, biologic, drug, intervention, process, or program), including:

- safety and efficacy;

- impact on health outcomes and patient management;

- indications for use; and

- patient selection criteria compared with the standard treatment/testing.

5.4 The contractor has the capability to provide shall be available via a fully searchable, web-based library, consisting of a minimum of 350 HTAs and 500 GTEs, which is accessible 24 hours per day.

5.5 The contractor has the capability to provide access to a minimum of 80 updated or new HTAs or

GTEs per year.

5.6 The contractor has the capability to provide a literature search annually for each HTA and GTE report to update the information and flag reports requiring updating.

5. DISCLAIMER AND IMPORTANT NOTES:

THIS NOTICE IS NOT A REQUEST FOR PROPOSALS. This notice constitutes solely a market research effort as described under FAR 10.002. This notice does not obligate the Government to award a potential contract or otherwise pay for the information provided in response.

The Government reserves the right to use results of the communications with industry for any purpose consistent with, and not otherwise prohibited by FAR Part 10. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, in no case shall responses to this notice be considered either a response to a solicitation or a submission of an unsolicited proposal, as defined by FAR 2.101.

6. CONFIDENTIALITY:

No proprietary, classified, confidential, or sensitive information should be included in your response.

Industry responses will be shared with DHA staff for the purpose of market research. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

7. NEXT STEPS:

Submittals should be emailed to the contract specialist on or before 1700 Hours EST on 15 August

The Government is performing market research by way of this Special Notice. IAW FAR 15.201, this is a Request for

Information only. Responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract.

2025.

8. RFI SUBMISSION STRUCTURE:

8.1. GENERAL RESPONSE GUIDANCE. All vendors are asked to provide responses using the following parameters for submission, file types, and response length:

8.1.1. All responses are to be in Microsoft WORD format and or as a PDF.

8.1.2. Models and diagrams in MS VISIO document and or as a PDF.

8.1.3. The responses shall be no longer than to 20 pages total.

8.2. The following information should be included in your response:

8.2.1. Company / team / solution ownership.

8.2.2. Contract and or Teaming strategy.

8.2.3. Business Type; NAICS, Hub Zone and Small/Large.

8.2.4. Facility for any cleared activities.

8.2.5. All forms of POC info; phone address, fax, mail designated POC.

9. PRIMARY POINTS OF CONTACT: Submit RFI response and/or questions to the DHA contracting team at email: peichang.wang.civ@health.mil mailto:peichang.wang.civ@health.mil